312 related articles for article (PubMed ID: 15784559)
1. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.
Peterson ML; Ault K; Kremer MJ; Klingelhutz AJ; Davis CC; Squier CA; Schlievert PM
Infect Immun; 2005 Apr; 73(4):2164-74. PubMed ID: 15784559
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
Schlievert PM; Cahill MP; Hostager BS; Brosnahan AJ; Klingelhutz AJ; Gourronc FA; Bishop GA; Leung DYM
mBio; 2019 Mar; 10(2):. PubMed ID: 30890614
[TBL] [Abstract][Full Text] [Related]
3. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.
Schaefers MM; Breshears LM; Anderson MJ; Lin YC; Grill AE; Panyam J; Southern PJ; Schlievert PM; Peterson ML
PLoS One; 2012; 7(3):e32813. PubMed ID: 22431984
[TBL] [Abstract][Full Text] [Related]
4. Use of porcine vaginal tissue ex-vivo to model environmental effects on vaginal mucosa to toxic shock syndrome toxin-1.
Davis CC; Baccam M; Mantz MJ; Osborn TW; Hill DR; Squier CA
Toxicol Appl Pharmacol; 2014 Jan; 274(2):240-8. PubMed ID: 24333258
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Toxic Shock Syndrome-Associated
Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
[TBL] [Abstract][Full Text] [Related]
6. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
7. Novel toxic shock syndrome toxin-1 amino acids required for biological activity.
Brosnahan AJ; Schaefers MM; Amundson WH; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
Biochemistry; 2008 Dec; 47(49):12995-3003. PubMed ID: 19012411
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal TSST-1 Association with Eczema Herpeticum in Humans.
Schlievert PM; Roller RJ; Kilgore SH; Villarreal M; Klingelhutz AJ; Leung DYM
mSphere; 2021 Aug; 6(4):e0060821. PubMed ID: 34319127
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor Receptor Signaling Enhances the Proinflammatory Effects of Staphylococcus aureus Gamma-Toxin on the Mucosa.
Gillman AN; Breshears LM; Kistler CK; Finnegan PM; Torres VJ; Schlievert PM; Peterson ML
Toxins (Basel); 2017 Jun; 9(7):. PubMed ID: 28657583
[No Abstract] [Full Text] [Related]
10. Vaginal community state types (CSTs) alter environmental cues and production of the
Maduta CS; McCormick JK; Dufresne K
J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
[TBL] [Abstract][Full Text] [Related]
11. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).
Breshears LM; Schlievert PM; Peterson ML
J Biol Chem; 2012 Sep; 287(39):32578-87. PubMed ID: 22833676
[TBL] [Abstract][Full Text] [Related]
12. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
13. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
14. The SaeRS Two-Component System Is a Direct and Dominant Transcriptional Activator of Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus.
Baroja ML; Herfst CA; Kasper KJ; Xu SX; Gillett DA; Li J; Reid G; McCormick JK
J Bacteriol; 2016 Oct; 198(19):2732-42. PubMed ID: 27457715
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.
Lin YC; Anderson MJ; Kohler PL; Strandberg KL; Olson ME; Horswill AR; Schlievert PM; Peterson ML
Biochemistry; 2011 Aug; 50(33):7157-67. PubMed ID: 21749039
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.
Rosten PM; Bartlett KH; Chow AW
J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927
[TBL] [Abstract][Full Text] [Related]
18. Cytolysins augment superantigen penetration of stratified mucosa.
Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
[TBL] [Abstract][Full Text] [Related]
19. In vitro studies of toxic shock toxin-1-secreting Staphylococcus aureus and implications for burn care in children.
Laabei M; Young A; Jenkins TA
Pediatr Infect Dis J; 2012 May; 31(5):e73-7. PubMed ID: 22301473
[TBL] [Abstract][Full Text] [Related]
20. The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function.
Kulhankova K; Kinney KJ; Stach JM; Gourronc FA; Grumbach IM; Klingelhutz AJ; Salgado-Pabón W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29229737
[No Abstract] [Full Text] [Related]
[Next] [New Search]
